Prolonged Suppression of Bacterial Growth in Urine Culture Following Fluoroquinolone Therapy in an Elderly Diabetic Patient: A Diagnostic Pitfall
Abstract
Abstract Urine culture is the gold standard for diagnosing urinary tract infections (UTIs), but prior antibiotic therapy can cause false-negative results. Fluoroquinolones (FQs), commonly used for complicated UTIs, may cause prolonged post-antibiotic effect (PAE), particularly in high-risk patients. We report an 81-year-old diabetic woman with persistent urinary symptoms who received empirical levofloxacin (LFX) therapy. Despite adherence to treatment and repeated urine cultures showing bacteriuria on microscopy, urine cultures remained negative for 10 days following antibiotic discontinuation, and subsequently became positive for FQ-resistant Escherichia coli. Renal ultrasonography revealed incidental simple cysts without obstruction or acute pathology. This case highlights a diagnostic pitfall of prolonged suppression of bacterial growth in urine cultures following FQ therapy. This effect may be more pronounced in elderly patients with comorbidities. Clinicians should interpret urine cultures cautiously after FQ use in high-risk patients, and consider repeat sampling when clinical suspicion persists. As a single-case report, the findings may not be generalizable to broader patient populations and should be interpreted with caution.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.